Intranasal Immunization with a Recombinant Avian Paramyxovirus Serotypes 2 Vector-Based Vaccine Induces Protection against H9N2 Avian Influenza in Chicken
Open Access
Abstract
Commercial inactivated vaccines against H9N2 avian influenza (AI) have been developed in China since 1990s and show excellent immunogenicity with strong HI antibodies. However, currently approved vaccines cannot meet the clinical demand for a live-vectored vaccine. Newcastle disease virus (NDV) vectored vaccines have shown effective protection in chickens against H9N2 virus. However, preexisting NDV antibodies may affect protective efficacy of the vaccine in the field. Here, we explored avian paramyxovirus serotype 2 (APMV-2) as a vector for developing an H9N2 vaccine via intranasal delivery. APMV-2 belongs to the same genus as NDV, distantly related to NDV in the phylogenetic tree, based on the sequences of Fusion (F) and hemagglutinin-neuraminidase (HN) gene, and has low cross-reactivity with anti-NDV antisera. We incorporated hemagglutinin (HA) of H9N2 into the junction of P and M gene in the APMV-2 genome by being flanked with the gene start, gene end, and UTR of each gene of APMV-2-T4 to generate seven recombinant APMV-2 viruses rAPMV-2/HAs, rAPMV-2-NPUTR-HA, rAPMV-2-PUTR-HA, rAPMV-2-FUTR-HA, rAPMV-2-HNUTR-HA, rAPMV-2-LUTR-HA, and rAPMV-2-MUTR-HA, expressing HA. The rAPMV-2/HAs displayed similar pathogenicity compared with the parental APMV-2-T4 virus and expressed HA protein in infected CEF cells. The NP-UTR facilitated the expression and secretion of HA protein in cells infected with rAPMV-2-NPUTR-HA. Animal studies demonstrated that immunization with rAPMV-2-NPUTR-HA elicited effective H9N2-specific antibody (6.14 ± 1.2 log2) responses and conferred complete immune protection to prevent viral shedding in the oropharyngeal and cloacal swabs from chickens challenged with H9N2 virus. This study suggests that our recombinant APMV-2 virus is safe and immunogenic and can be a useful tool in the combat of H9N2 outbreaks in chicken.Keywords
Funding Information
- Earmarked Fund for China Agriculture Research System (CARS-40, 2021YFD1800202-1, 31772755, R1808)
- National Key Research and Development Project of China (CARS-40, 2021YFD1800202-1, 31772755, R1808)
- National Natural Science Foundation of China (CARS-40, 2021YFD1800202-1, 31772755, R1808)
- Open Project Program of Jiangsu Key Laboratory of Zoonosis (CARS-40, 2021YFD1800202-1, 31772755, R1808)
- Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (CARS-40, 2021YFD1800202-1, 31772755, R1808)
This publication has 49 references indexed in Scilit:
- Risk Perceptions for Avian Influenza Virus Infection among Poultry Workers, ChinaEmerging Infectious Diseases, 2013
- Avian paramyxovirus serotypes 2-9 (APMV-2-9) vary in the ability to induce protective immunity in chickens against challenge with virulent Newcastle disease virus (APMV-1)Vaccine, 2012
- Elements in the Canine Distemper Virus M 3′ UTR Contribute to Control of Replication Efficiency and VirulencePLOS ONE, 2012
- Reassortant H9N2 Influenza Viruses Containing H5N1-Like PB1 Genes Isolated from Black-Billed Magpies in Southern ChinaPLOS ONE, 2011
- Complete genome sequences of avian paramyxovirus serotype 2 (APMV-2) strains Bangor, England and Kenya: Evidence for the existence of subgroups within serotype 2Virus Research, 2010
- Role of Untranslated Regions in Regulation of Gene Expression, Replication, and Pathogenicity of Newcastle Disease Virus Expressing Green Fluorescent ProteinJournal of Virology, 2010
- A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in miceBMC Infectious Diseases, 2009
- Newcastle Disease Virus-Based Live Attenuated Vaccine Completely Protects Chickens and Mice from Lethal Challenge of Homologous and Heterologous H5N1 Avian Influenza VirusesJournal of Virology, 2007
- Engineered viral vaccine constructs with dual specificity: Avian influenza and Newcastle diseaseProceedings of the National Academy of Sciences, 2006
- Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenzaProceedings of the National Academy of Sciences, 2006